CCR4
Basic information
Region (hg38): 3:32951644-32957120
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCR4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 16 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 16 | 1 | 0 |
Variants in CCR4
This is a list of pathogenic ClinVar variants found in the CCR4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-32953465-A-G | not specified | Uncertain significance (Jan 10, 2023) | ||
3-32953484-T-A | not specified | Uncertain significance (Jan 06, 2023) | ||
3-32953626-G-T | not specified | Uncertain significance (Mar 07, 2024) | ||
3-32953685-T-G | not specified | Uncertain significance (Jul 20, 2022) | ||
3-32953813-A-G | not specified | Uncertain significance (Feb 28, 2024) | ||
3-32953952-C-T | not specified | Uncertain significance (Sep 29, 2023) | ||
3-32954046-T-G | not specified | Uncertain significance (Aug 11, 2022) | ||
3-32954094-G-T | not specified | Uncertain significance (Jul 06, 2022) | ||
3-32954110-C-A | not specified | Uncertain significance (Nov 18, 2022) | ||
3-32954159-C-T | not specified | Uncertain significance (Jul 06, 2021) | ||
3-32954167-G-A | not specified | Uncertain significance (May 25, 2022) | ||
3-32954188-A-G | not specified | Uncertain significance (Dec 08, 2023) | ||
3-32954200-A-G | not specified | Likely benign (Dec 01, 2022) | ||
3-32954201-T-C | not specified | Uncertain significance (Oct 22, 2021) | ||
3-32954401-G-A | not specified | Uncertain significance (Jan 23, 2023) | ||
3-32954402-T-G | not specified | Uncertain significance (Jun 07, 2024) | ||
3-32954407-T-G | not specified | Uncertain significance (Jan 24, 2024) | ||
3-32954422-C-G | not specified | Uncertain significance (Jan 06, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCR4 | protein_coding | protein_coding | ENST00000330953 | 1 | 4776 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0686 | 0.878 | 125738 | 0 | 10 | 125748 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.746 | 164 | 193 | 0.849 | 0.0000101 | 2365 |
Missense in Polyphen | 42 | 79.078 | 0.53112 | 985 | ||
Synonymous | -1.74 | 101 | 81.1 | 1.25 | 0.00000457 | 728 |
Loss of Function | 1.63 | 3 | 7.97 | 0.377 | 3.39e-7 | 117 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000528 | 0.0000527 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000654 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: High affinity receptor for the C-C type chemokines CCL17/TARC, CCL22/MDC and CKLF isoform 1/CKLF1. The activity of this receptor is mediated by G(i) proteins which activate a phosphatidylinositol-calcium second messenger system. Can function as a chemoattractant homing receptor on circulating memory lymphocytes and as a coreceptor for some primary HIV-2 isolates. In the CNS, could mediate hippocampal-neuron survival. {ECO:0000269|PubMed:10466728, ECO:0000269|PubMed:10754297, ECO:0000269|PubMed:16137713, ECO:0000269|PubMed:9169480, ECO:0000269|PubMed:9430724}.;
- Pathway
- Kaposi,s sarcoma-associated herpesvirus infection - Homo sapiens (human);Chemokine signaling pathway - Homo sapiens (human);Viral carcinogenesis - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);Peptide GPCRs;Chemokine signaling pathway;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Chemokine receptors bind chemokines;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (i) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.124
Intolerance Scores
- loftool
- 0.338
- rvis_EVS
- -0.29
- rvis_percentile_EVS
- 32.94
Haploinsufficiency Scores
- pHI
- 0.164
- hipred
- Y
- hipred_score
- 0.515
- ghis
- 0.520
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.674
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ccr4
- Phenotype
- immune system phenotype; respiratory system phenotype; hematopoietic system phenotype;
Gene ontology
- Biological process
- neuron migration;tolerance induction;chemotaxis;inflammatory response;immune response;G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;response to radiation;response to bacterium;calcium-mediated signaling;response to antibiotic;homeostasis of number of cells;positive regulation of positive chemotaxis;cell chemotaxis;chemokine-mediated signaling pathway
- Cellular component
- plasma membrane;integral component of plasma membrane;external side of plasma membrane;neuronal cell body
- Molecular function
- chemokine receptor activity;protein binding;C-C chemokine receptor activity;chemokine binding;C-C chemokine binding